Select a medication above to begin.
Daytrana
methylphenidate transdermal
Black Box Warnings .
Abuse, Misuse, and Addiction
CNS stimulants have high potential for abuse and misuse, can lead to substance use disorder, incl. addiction; misuse and abuse can result in overdose and death, risk incr. w/ higher doses or unapproved admin. methods; assess risk for abuse, misuse, and addiction before prescribing and throughout tx; educate pts and families about risks and proper drug storage and disposal; monitor frequently for s/sx of abuse, misuse, and addiction during tx
Adult Dosing .
Dosage forms: PATCH: 10 mg per 9h, 15 mg per 9h, 20 mg per 9h, 30 mg per 9h
ADHD (off-label)
- [apply 1 patch qd x9h, off x15h]
- Start: apply 10 mg patch qd x9h, off x15h; may incr. to next size patch q7 days; Max: 30 mg patch qd; Info: apply 2h before desired effect; duration 3-5h after removal; use same titration when converting from PO; do not alter/cut patch
renal dosing
- [not defined]
- renal impairment: not defined
- HD/PD: not defined
hepatic dosing
- [not defined]
Peds Dosing .
- Dosage forms: PATCH: 10 mg per 9h, 15 mg per 9h, 20 mg per 9h, 30 mg per 9h
ADHD
- [6 yo and older]
- Dose: apply 1 patch qd x9h, off x15h; Start: apply 10 mg patch qd x9h, off x15h; may incr. to next size patch q7 days; Max: 30 mg patch qd; Info: apply 2h before desired effect; duration 3-5h after removal; use same titration when converting from PO; do not alter/cut patch
renal dosing
- [not defined]
- renal impairment: not defined
- HD/PD: not defined
hepatic dosing
- [not defined]